These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34779410)

  • 1. Folliculin impairs breast tumor growth by repressing TFE3-dependent induction of the Warburg effect and angiogenesis.
    El-Houjeiri L; Biondini M; Paquette M; Kuasne H; Pacis A; Park M; Siegel PM; Pause A
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR.
    Collodet C; Foretz M; Deak M; Bultot L; Metairon S; Viollet B; Lefebvre G; Raymond F; Parisi A; Civiletto G; Gut P; Descombes P; Sakamoto K
    FASEB J; 2019 Nov; 33(11):12374-12391. PubMed ID: 31404503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.
    Yan M; Gingras MC; Dunlop EA; Nouët Y; Dupuy F; Jalali Z; Possik E; Coull BJ; Kharitidi D; Dydensborg AB; Faubert B; Kamps M; Sabourin S; Preston RS; Davies DM; Roughead T; Chotard L; van Steensel MA; Jones R; Tee AR; Pause A
    J Clin Invest; 2014 Jun; 124(6):2640-50. PubMed ID: 24762438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.
    Hong SB; Oh H; Valera VA; Baba M; Schmidt LS; Linehan WM
    PLoS One; 2010 Dec; 5(12):e15793. PubMed ID: 21209915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen Resistance.
    El-Houjeiri L; Possik E; Vijayaraghavan T; Paquette M; Martina JA; Kazan JM; Ma EH; Jones R; Blanchette P; Puertollano R; Pause A
    Cell Rep; 2019 Mar; 26(13):3613-3628.e6. PubMed ID: 30917316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue.
    Wada S; Neinast M; Jang C; Ibrahim YH; Lee G; Babu A; Li J; Hoshino A; Rowe GC; Rhee J; Martina JA; Puertollano R; Blenis J; Morley M; Baur JA; Seale P; Arany Z
    Genes Dev; 2016 Nov; 30(22):2551-2564. PubMed ID: 27913603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLCN: The causative gene for Birt-Hogg-Dubé syndrome.
    Schmidt LS; Linehan WM
    Gene; 2018 Jan; 640():28-42. PubMed ID: 28970150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folliculin: A Regulator of Transcription Through AMPK and mTOR Signaling Pathways.
    Ramirez Reyes JMJ; Cuesta R; Pause A
    Front Cell Dev Biol; 2021; 9():667311. PubMed ID: 33981707
    [No Abstract]   [Full Text] [Related]  

  • 10. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3.
    Paquette M; El-Houjeiri L; C Zirden L; Puustinen P; Blanchette P; Jeong H; Dejgaard K; Siegel PM; Pause A
    Autophagy; 2021 Dec; 17(12):3957-3975. PubMed ID: 33734022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
    Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.
    Isono Y; Furuya M; Kuwahara T; Sano D; Suzuki K; Jikuya R; Mitome T; Otake S; Kawahara T; Ito Y; Muraoka K; Nakaigawa N; Kimura Y; Baba M; Nagahama K; Takahata H; Saito I; Schmidt LS; Linehan WM; Kodama T; Yao M; Oridate N; Hasumi H
    Biochem Biophys Res Commun; 2020 Feb; 522(4):931-938. PubMed ID: 31806376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
    Takagi Y; Kobayashi T; Shiono M; Wang L; Piao X; Sun G; Zhang D; Abe M; Hagiwara Y; Takahashi K; Hino O
    Oncogene; 2008 Sep; 27(40):5339-47. PubMed ID: 18663353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome Activity.
    Endoh M; Baba M; Endoh T; Hirayama A; Nakamura-Ishizu A; Umemoto T; Hashimoto M; Nagashima K; Soga T; Lang M; Schmidt LS; Linehan WM; Suda T
    Cell Rep; 2020 Feb; 30(6):1823-1834.e5. PubMed ID: 32049013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3.
    Ramírez JA; Iwata T; Park H; Tsang M; Kang J; Cui K; Kwong W; James RG; Baba M; Schmidt LS; Iritani BM
    J Immunol; 2019 Dec; 203(11):2899-2908. PubMed ID: 31676673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
    Di Malta C; Zampelli A; Granieri L; Vilardo C; De Cegli R; Cinque L; Nusco E; Pece S; Tosoni D; Sanguedolce F; Sorrentino NC; Merino MJ; Nielsen D; Srinivasan R; Ball MW; Ricketts CJ; Vocke CD; Lang M; Karim B; Lanfrancone L; Schmidt LS; Linehan WM; Ballabio A
    EMBO Mol Med; 2023 May; 15(5):e16877. PubMed ID: 36987696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FLCN inhibits canonical WNT signaling via TFE3.
    Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP
    Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells.
    Glykofridis IE; Knol JC; Balk JA; Westland D; Pham TV; Piersma SR; Lougheed SM; Derakhshan S; Veen P; Rooimans MA; van Mil SE; Böttger F; Poddighe PJ; van de Beek I; Drost J; Zwartkruis FJ; de Menezes RX; Meijers-Heijboer HE; Houweling AC; Jimenez CR; Wolthuis RM
    Elife; 2021 Jan; 10():. PubMed ID: 33459596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.
    Nagashima K; Fukushima H; Shimizu K; Yamada A; Hidaka M; Hasumi H; Ikebe T; Fukumoto S; Okabe K; Inuzuka H
    Oncotarget; 2017 Feb; 8(6):9947-9960. PubMed ID: 28039480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
    Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.